SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 182,877.37 |
Enterprise Value ($M) | 202,287.37 |
Book Value ($M) | 61,704.00 |
Book Value / Share | 28.41 |
Price / Book | 2.96 |
NCAV ($M) | -26,278.00 |
NCAV / Share | -12.10 |
Price / NCAV | -6.96 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.25 |
Return on Assets (ROA) | 0.20 |
Return on Equity (ROE) | 0.48 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.01 |
Current Ratio | 1.25 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 37,236.00 |
Assets | 125,218.00 |
Liabilities | 63,514.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 52,877.00 |
Operating Income | 13,036.00 |
Net Income | 24,021.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 15,071.00 |
Cash from Investing | 4,208.00 |
Cash from Financing | -16,264.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | BlackRock Inc. | 5.70 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
117,660 | 1,502,922 | 7.83 | |
224,683 | 1,946,266 | 11.54 | |
137,265 | 1,774,862 | 7.73 | |
149,059 | 1,652,692 | 9.02 | |
(click for more detail) |
|||
(click for list of largest short owners) |
Similar Companies | |
---|---|
MYOV – Myovant Sciences Ltd. | NUVB – Nuvation Bio Inc |
NVO – Novo-Nordisk A/S | OGN – Organon & Co. |
PBH – Prestige Brands Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io